Skip to main content
EMGALITY 100 mg/mL injection, solution by Eli Lilly and Company
EMGALITY, 100 mg/mL, injection, solution Available on prescription only. Listed by Eli Lilly and Company.
Prescription only

EMGALITY

galcanezumab-gnlm

Listed by Eli Lilly and Company

Strength
100 mg/mL
Form
Injection, Solution
Route
Subcutaneous

What it contains

  • Galcanezumab 100 mg/mL

FDA record

Dosage form Injection, Solution
Route Subcutaneous
Approval route BLA — biologic licence
NDC code 0002-3115
FDA application BLA761063
RxNorm concept 2058872
Package sizes listed 1
Marketed since June 2019

Other products containing Galcanezumab

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

EMGALITY

galcanezumab-gnlm

Strength
120 mg/mL
Form
Injection, Solution
Rx only

Eli Lilly and Company

Not stocked by us — reference only

EMGALITY

galcanezumab-gnlm

Strength
120 mg/mL
Form
Injection, Solution
Rx only

Eli Lilly and Company

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.